Verrica Pharmaceuticals Inc. (VRCA) SEC filings
VRCA SEC filings moved a median of -2.67% by the close. VRCA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the VRCA overview →
70 measured VRCA SEC filing events.
Where these VRCA SEC filings landedvs 70 measured VRCA SEC filing reactions
| Middle 50% of VRCA SEC filing reactions | -5.67% to +1.57% |
|---|---|
| Median reaction (to close) | -2.67% |
| Measured reactions | 70 |
Point-in-time · zero look-ahead
Half of the 70 VRCA SEC filing events with a measured close landed between -5.67% and +1.57%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Verrica Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +1.41% | -4.33% | |
| Form 8-K Verrica Pharmaceuticals For: Aug 06 | SEC filing · Form 8-K | +1.41% | -4.33% | |
| Form 8-K Verrica Pharmaceuticals For: Jun 05 | SEC filing · Form 8-K | +0.00% | -2.71% | |
| Form 10-Q Verrica Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.51% | +6.66% | |
| Form 8-K Verrica Pharmaceuticals For: May 12 | SEC filing · Form 8-K | +0.51% | +6.66% | |
| Form S-8 Verrica Pharmaceuticals | SEC filing · Form S-8 | +0.51% | +6.66% | |
| Form ARS Verrica Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +0.31% | -1.25% | |
| Form DEF 14A Verrica Pharmaceuticals For: Jun 05 | SEC filing · Form DEF | +0.31% | -1.25% | |
| Form DEFA14A Verrica Pharmaceuticals | SEC filing · Form DEFA14A | +0.31% | -1.25% | |
| Form 10-K Verrica Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +14.26% | +23.96% | |
| Form 8-K Verrica Pharmaceuticals For: Mar 11 | SEC filing · Form 8-K | +14.26% | +23.96% | |
| Form 8-K Verrica Pharmaceuticals For: Dec 23 | SEC filing · Form 8-K | +0.61% | +1.47% | |
| Form EFFECT Verrica Pharmaceuticals | SEC filing · Form EFFECT | +2.13% | +2.63% | |
| Form S-3 Verrica Pharmaceuticals | SEC filing · Form S-3 | -2.56% | +15.90% | |
| Form D Verrica Pharmaceuticals | SEC filing · Form D | -1.75% | +0.36% | |
| Form 8-K Verrica Pharmaceuticals For: Nov 23 | SEC filing · Form 8-K | +2.54% | +0.00% | |
| Form 10-Q Verrica Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.87% | |
| Form 8-K Verrica Pharmaceuticals For: Nov 14 | SEC filing · Form 8-K | +0.00% | -2.87% | |
| Form 10-Q Verrica Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -2.84% | -6.53% | |
| Form 8-K Verrica Pharmaceuticals For: Aug 08 | SEC filing · Form 8-K | -2.84% | -6.53% | |
| Form 8-K Verrica Pharmaceuticals For: Jul 24 | SEC filing · Form 8-K | +3.83% | -4.25% | |
| Form 8-K Verrica Pharmaceuticals For: Jul 22 | SEC filing · Form 8-K | +0.00% | -0.73% | |
| Form 8-K Verrica Pharmaceuticals For: Jun 27 | SEC filing · Form 8-K | +15.21% | +10.68% | |
| Form 8-K Verrica Pharmaceuticals For: Jun 10 | SEC filing · Form 8-K | +1.77% | -3.19% | |
| Form 8-K Verrica Pharmaceuticals For: Jun 05 | SEC filing · Form 8-K | +2.00% | +8.25% | |
| Form 10-Q Verrica Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -8.86% | -2.67% | |
| Form 8-K Verrica Pharmaceuticals For: May 13 | SEC filing · Form 8-K | -8.86% | -2.67% | |
| Form S-8 Verrica Pharmaceuticals | SEC filing · Form S-8 | -8.86% | -2.67% | |
| Form DEFR14A Verrica Pharmaceuticals | SEC filing · Form DEFR14A | +1.08% | +0.37% | |
| Form 8-K Verrica Pharmaceuticals For: Apr 22 | SEC filing · Form 8-K | -0.02% | -6.17% | |
| Form ARS Verrica Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +5.62% | -1.06% | |
| Form DEF 14A Verrica Pharmaceuticals For: Jun 05 | SEC filing · Form DEF | +5.62% | -1.06% | |
| Form DEFA14A Verrica Pharmaceuticals | SEC filing · Form DEFA14A | +5.62% | -1.06% | |
| Form PRE 14A Verrica Pharmaceuticals For: Jun 05 | SEC filing · Form PRE | +11.68% | +14.88% | |
| Form 8-K Verrica Pharmaceuticals For: Mar 31 | SEC filing · Form 8-K | -8.66% | +0.53% | |
| Form EFFECT Verrica Pharmaceuticals | SEC filing · Form EFFECT | +1.03% | -7.40% | |
| Form 10-K Verrica Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -3.17% | -4.71% | |
| Form 8-K Verrica Pharmaceuticals For: Mar 11 | SEC filing · Form 8-K | -3.17% | -4.71% | |
| Form S-3 Verrica Pharmaceuticals | SEC filing · Form S-3 | -3.17% | -4.71% | |
| Form 8-K Verrica Pharmaceuticals For: Feb 18 | SEC filing · Form 8-K | -2.63% | -9.34% | |
| Form 8-K Verrica Pharmaceuticals For: Jan 24 | SEC filing · Form 8-K | +0.00% | -11.75% | |
| Form 8-K Verrica Pharmaceuticals For: Dec 04 | SEC filing · Form 8-K | +0.01% | -4.84% | |
| Form S-8 Verrica Pharmaceuticals | SEC filing · Form S-8 | +0.01% | -4.84% | |
| Form 8-K Verrica Pharmaceuticals For: Nov 20 | SEC filing · Form 8-K | +1.69% | +1.23% | |
| Form 8-K Verrica Pharmaceuticals For: Nov 20 | SEC filing · Form 8-K | -0.89% | +10.49% | |
| Form S-8 Verrica Pharmaceuticals | SEC filing · Form S-8 | -4.07% | -6.09% | |
| Form 10-Q Verrica Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -3.80% | -14.25% | |
| Form 8-K Verrica Pharmaceuticals For: Nov 01 | SEC filing · Form 8-K | -3.80% | -14.25% | |
| Form 8-K Verrica Pharmaceuticals For: Oct 02 | SEC filing · Form 8-K | -1.08% | -1.54% | |
| Form 8-K Verrica Pharmaceuticals For: Oct 01 | SEC filing · Form 8-K | +0.73% | -18.38% | |
| Form 8-K Verrica Pharmaceuticals For: Sep 23 | SEC filing · Form 8-K | +1.21% | -12.12% | |
| Form 8-K Verrica Pharmaceuticals For: Aug 30 | SEC filing · Form 8-K | -0.77% | -1.55% | |
| Form 8-K Verrica Pharmaceuticals For: Aug 21 | SEC filing · Form 8-K | +0.41% | -4.51% | |
| Form 10-Q Verrica Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -10.44% | -40.80% | |
| Form 8-K Verrica Pharmaceuticals For: Aug 14 | SEC filing · Form 8-K | -10.44% | -40.80% | |
| Form 8-K Verrica Pharmaceuticals For: Aug 02 | SEC filing · Form 8-K | -0.18% | -4.24% | |
| Form 8-K Verrica Pharmaceuticals For: Jun 26 | SEC filing · Form 8-K | +2.22% | +11.50% | |
| Form 8-K Verrica Pharmaceuticals For: Jun 06 | SEC filing · Form 8-K | +0.00% | +4.44% | |
| Form 8-K Verrica Pharmaceuticals For: May 14 | SEC filing · Form 8-K | +0.57% | -4.21% | |
| Form 10-Q Verrica Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -1.22% | +16.30% | |
| Form 8-K Verrica Pharmaceuticals For: May 13 | SEC filing · Form 8-K | -1.22% | +16.30% | |
| Form S-8 Verrica Pharmaceuticals | SEC filing · Form S-8 | +3.62% | -4.53% | |
| Form ARS Verrica Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +0.00% | +1.60% | |
| Form DEF 14A Verrica Pharmaceuticals For: Jun 06 | SEC filing · Form DEF | +0.00% | +1.60% | |
| Form DEFA14A Verrica Pharmaceuticals | SEC filing · Form DEFA14A | +0.00% | +1.60% | |
| Form 10-K Verrica Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -1.88% | -10.07% | |
| Form 8-K Verrica Pharmaceuticals For: Feb 29 | SEC filing · Form 8-K | -1.88% | -10.07% | |
| Form 8-K Verrica Pharmaceuticals For: Jan 08 | SEC filing · Form 8-K | -1.49% | -5.95% | |
| Form 10-Q Verrica Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -1.39% | -10.83% | |
| Form 8-K Verrica Pharmaceuticals For: Nov 09 | SEC filing · Form 8-K | -1.39% | -10.83% |
Keep exploring
More VRCA: earnings → · analyst actions → · VRCA overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Achieve Life Sciences, Inc. - Common Shares (ACHV) | 269 | -0.54% | 42% |
| CorMedix Inc. (CRMD) | 269 | -0.42% | 39% |
| CONMED Corporation (CNMD) | 268 | -0.11% | 47% |
| Codexis, Inc. (CDXS) | 267 | 0.00% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.